In a standing room only session at ENDO 2013 in San Francisco, CA, expert faculty led discussions on transgender medicine and how to improve the daily clinical practice. Transgender medicine has increased visibility among the endocrine community, in large part related to publication of The Endocrine Society's guidelines (2009) and the World Professional Association for Transgender Health's Standards of Care (2011). Yet uncertainties exist in the endocrine community.

This special session was designed to address those uncertainties by discussing the insights on the mechanisms of gender dysphoria, approaches to psychological and medical treatment, and effectiveness and safety of hormonal treatment. The audience and faculty led highly engaging discussion on areas in mechanism, medical treatment, and outcomes, which can watched freely online.


Includes the following presentations:

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of this site have already been set. To find out more about the cookies we use and how to delete them, see our privacy policy.

  I accept cookies from this site.
EU Cookie Directive Module Information